JP Stock MarketDetailed Quotes
4594 BrightPath Biotherapeutics
- 49
- -1-2.00%
20min DelayNot Open Oct 4 15:00 JST
4.06BMarket Cap-2690P/E (Static)
50High48Low825.00KVolume49Open50Pre Close40.41MTurnover12952wk High1.04%Turnover Ratio82.79MShares4352wk Low-18.21EPS TTM3.89BFloat Cap2229Historical HighLossP/E (Static)79.46MShs Float43Historical Low-18.21EPS LYR4.00%Amplitude--Dividend TTM3.56P/B100Lot Size--Div YieldTTM
About BrightPath Biotherapeutics Company
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
Company Profile
Symbol4594
Company NameBrightPath Biotherapeutics
Founded2003-05-08
MarketTSE Growth
Fiscal Year Ends03-31
Address2-2-4 Kojimachi Kojimachi Central Building 7th Floor
Zip Code102-0083
Phone03-5840-7697
Websitewww.brightpathbio.com
Company Executives
- Name
- Position
- Salary
- Yoichi Takeshita
- Director and Chief Financial Officer
- --
- Kenichi Nagai
- Representative Director and President
- --
- Tokuhiro Nakamura
- Director and Director of Drug Discovery Research
- --
- Ryo Yamada
- Director
- --
- Hirotaka Takeuchi
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data